OpenMed’s pitch is a simple equation. In Latin America, independent pharmacies, or boticas, are the primary point of pharmaceutical distribution. They are also fragmented, under-digitized, and often starved for working capital. The Miami-based, Peru-operating startup is betting it can solve all three problems at once. It connects these pharmacies directly to laboratories via a mobile app, promises next-day delivery on a catalog of over 2,500 products, and wraps the transaction in financial services [Infomercado, Apr 2023]. The goal is to become the principal digital artery for a supply chain that still runs largely on paper and personal relationships.
The pharmacy-as-a-service wedge
OpenMed’s initial wedge is logistics. The company’s app gives a botica owner a single digital storefront to order everything from prescription medicines to beauty and personal care products, bypassing traditional, multi-layered distributors [Infomercado, Apr 2023]. The promise of next-day delivery addresses a critical pain point in a region where inventory management can be erratic. This operational efficiency is the entry point. The more strategic play, however, is embedded in the company’s full tagline: “marketplace… with financial services.” By digitizing the procurement workflow, OpenMed positions itself to see transaction volume and inventory needs in real-time. That data layer is the foundation for offering credit, inventory financing, or other working capital products specifically tailored to small pharmacy owners,a segment often overlooked by traditional banks.
A four-founder build
The company is led by a quartet of co-founders, each owning a clear functional slice. Angelo Vásquez serves as CEO, Harold Gutiérrez as CTO, Renzo Rosas as CPO, and Karina Flores as Head of UX/UI [Infomercado, Apr 2023]. Their public profiles suggest a product-focused, engineering-driven team built to execute on the digital platform first. Gutiérrez’s listed expertise spans full-stack development, cloud engineering, and DevSecOps, while Flores focuses on product design and UX research [LinkedIn]. This composition points to a build mentality centered on user experience and technical reliability, essential for winning the trust of small business owners.
The counter-bet: scaling trust and liquidity
The model’s elegance faces two concrete tests. The first is scaling trust in a relationship-driven industry. Laboratories must be convinced to allocate volume through a new digital intermediary, and pharmacies must adopt a new purchasing habit. The second, larger hurdle is capital. Providing financial services requires a balance sheet. The company’s disclosed $5 million seed round provides a war chest, but the round’s lead investor remains unnamed in the public record. The sustainability of the financial services layer will depend on securing deeper institutional capital or banking partnerships to fund the lending book. Furthermore, they are not alone. Domestic competitor Boticas Perú operates in the same market, proving the need is recognized.
The company’s known traction rests on a few key, early signals:
- The seed round. A total of $5 million in disclosed funding anchors the venture, though the investor syndicate is not public.
- The product launch. The mobile app is live, offering a catalog reportedly exceeding 2,500 SKUs with next-day delivery guarantees [Infomercado, Apr 2023].
- The team build. The four co-founders cover the core competencies of product, technology, design, and operations required to launch and iterate.
For a company founded in 2015, the path to its current seed-stage marketplace model appears to have been iterative. The next phase is less about product iteration and more about commercial acceleration. Can OpenMed convert its initial pharmacy users into reliable financial services customers, and in doing so, prove the unit economics that would attract a Series A? The $5 million seed says someone believes the pharmacy counter is the right place to start.
Sources
- [Infomercado, Apr 2023] OpenMed la startup que busca convertirse en el principal Marketplace B2B de la industria farmacéutica | https://infomercado.pe/openmed-la-startup-que-busca-convertirse-en-el-principal-marketplace-b2b-de-la-industria-farmaceutica-280423-ru/
- [LinkedIn] Harold Gutierrez Profile | https://www.linkedin.com/in/openmed/
- [LinkedIn] Karina Flores Profile | https://www.linkedin.com/in/openmed/